Vera Therapeutics, Inc. - CL A (VERA)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / CL A
Shares, excl. options Q3 2024
53.5M
Holdings value Q3 2024
$2.36B
Value change Q3 2024
-$3.96M
Grand Portfolio weight change Q3 2024
0%
Number of holders
172
Number of buys Q3 2024
91
Number of sells Q3 2024
-74
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 53.5M $2.36B -$3.96M $44.20 172
2024 Q2 53M $1.92B +$57.8M $36.18 169
2024 Q1 51.3M $2.21B +$474M $43.12 157
2023 Q4 37.9M $583M +$44.8M $15.38 92
2023 Q3 39.3M $538M +$9.62M $13.71 84
2023 Q2 38.1M $612M +$42.6M $16.05 78
2023 Q1 37.4M $290M +$138M $7.76 69
2022 Q4 21.3M $413M -$7.25M $19.35 57
2022 Q3 21.5M $459M +$19.1M $21.31 55
2022 Q2 20.4M $278M +$7.85M $13.61 49
2022 Q1 19.5M $457M +$130M $23.49 49
2021 Q4 14.1M $375M +$10.5M $26.72 37
2021 Q3 14.7M $252M +$4.17M $17.35 30
2021 Q2 14.5M $186M +$186M $13.25 21